Zealand Pharma A/S ZEALAND PHARMA.../ DK0060257814 /
5/24/2024 6:34:53 PM | Chg. - | Volume | Bid4:55:01 PM | Ask4:55:01 PM | High | Low |
---|---|---|---|---|---|---|
583.50DKK | - | 21,510 Turnover: 9.35 mill. |
-Bid Size: - | -Ask Size: - | 588.50 | 567.50 |
GlobeNewswire
12:00 PM
Immutep successfully completes institutional placement and institutional component of entitlement of...
GlobeNewswire
12:00 PM
eXp Realty Enhances International Connections with Global Agent Referral Platform
GlobeNewswire
6/4
Dr. Ralph Thomas Champions Global Innovation with AGI54 Rollout Across 170 Resorts in Six Countries
GlobeNewswire
6/4
Surrozen Initiates Dosing of First Patient in Phase 1b Clinical Trial of SZN-043 for Severe Alcohol-...
GlobeNewswire
6/3
Novotech Launches Dedicated Early Phase Unit for Biotechs Leveraging the Australian and New Zealand ...
GlobeNewswire
5/31
Zealand Pharma announces positive CHMP opinion for dasiglucagon for treatment of severe hypoglycemia...
GlobeNewswire
5/29
Zealand Pharma to participate in upcoming healthcare investor conferences in June 2024
GlobeNewswire
5/23
Zealand Pharma announces topline results from the mechanistic investigator-led DREAM trial with low ...
GlobeNewswire
5/9
Zealand Pharma conference call on May 16 at 2pm CET (8am ET) to present first quarter 2024 financial...
GlobeNewswire
4/9
Optimi Health Signs Psilocybin Supply Agreement With New Zealand-Based Mātai Medical Research Instit...